Anti-PRMT1 antibody - ChIP Grade

• Supplier: Abcam
• Catalog: ab3768
• Prices: $401.00
• Sizes: 400 µl
• Host: Rabbit
• Clonality: Polyclonal
• Isotype: IgG
• Applications: WB ELISA IHC-P ChIP
• Species Reactivities: Rat, Human
• Antigen: Synthetic peptide: AKNNRDLDFT IDLDFKG , corresponding to amino acids 331-347 of Human PRMT 1
• Description: Rabbit Polyclonal
• Gene: PRMT1
• Conjugate: Unconjugated

Product images

ab3768 staining PRMT1 in human ductal carcinoma cells by Flow Cytometry. Cells were fixed with paraformaldehyde and permeabilized with permeabilization buffer. The sample was incubated with the undiluted primary antibody for 12 hours at 4°C. An Alexa Fluor® 488-conjugated goat polyclonal anti-rabbit IgG (1/1000) was used as the secondary antibody.Gating Strategy: Isotype negative control (white).See Abreview

  Sonicated Chromatin prepared from untreated or 17beta-estradiol (E2) treated MCF7 cells was subjected to the ChIP procedure with ab4441 to Histone H3 (acetyl K9) and the immunoprecipitated chromatin was analysed in the proximal region of the estrogen-responsive pS2 promoter (as shown above) and quantified by real-time PCR (values are % of inputs). The primers are designed to follow the nucleosome E (including the Estrogen Responsive Element ERE). 10 µl of ab3768 and 2x10Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - PRMT1 antibody - ChIP Grade (ab3768)ab3768 staining PRMT1 in human breast carcinoma (BC) tissue by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections).

Product References

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN - Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN

Valentijn LJ, Koster J, Haneveld F, Aissa RA, van Sluis P, Broekmans ME, Molenaar JJ, van Nes J, Versteeg R. Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19190-5. doi:

NIP45 controls the magnitude of the type 2 T helper cell response. - NIP45 controls the magnitude of the type 2 T helper cell response.

Fathman JW, Gurish MF, Hemmers S, Bonham K, Friend DS, Grusby MJ, Glimcher LH, Mowen KA. Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3663-8. doi:

BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic - BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic

van Galen JC, Kuiper RP, van Emst L, Levers M, Tijchon E, Scheijen B, Waanders E, van Reijmersdal SV, Gilissen C, van Kessel AG, Hoogerbrugge PM, van Leeuwen FN. Blood. 2010 Jun 10;115(23):4810-9.

Increasing dimethylarginine levels are associated with adverse clinical outcome - Increasing dimethylarginine levels are associated with adverse clinical outcome

Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C, Sen S, Williams R, Leiper J, Vallance P, Jalan R. Hepatology. 2007 Jan;45(1):62-71.

SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the - SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the

Wagner S, Weber S, Kleinschmidt MA, Nagata K, Bauer UM. J Biol Chem. 2006 Sep 15;281(37):27242-50. Epub 2006 Jul 20.

The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor - The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor

Rizzo G, Renga B, Antonelli E, Passeri D, Pellicciari R, Fiorucci S. Mol Pharmacol. 2005 Aug;68(2):551-8. Epub 2005 May 23.